bms-919373
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2014 (NCT02089061)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
NS(=O)(=O)c1cncc(-c2nc(NCc3ccccn3)c3c(-c4ccccc4)cccc3n2)c1- Mol. weight
- 468.54 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4094440 ↗
Also known as
- bms-919373
- bms-919373
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02153437 | Phase 1 | Oct 1, 2014 | Bristol-Myers Squibb |
| NCT02156076 | Phase 2 | Jul 1, 2014 | Bristol-Myers Squibb |
| NCT02089061 | Phase 1 | Mar 1, 2014 | Bristol-Myers Squibb |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bristol-Myers Squibb | For profit | 3 | 3 | 2 | 2014 |
1 organizations
Page 1 / 1